Anzeige
Mehr »
Login
Dienstag, 21.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News! 22 Jahre "BlueChip"-Power nun bei NurExone!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EWWY | ISIN: US92859E2072 | Ticker-Symbol:
NASDAQ
20.05.24
21:56 Uhr
2,245 US-Dollar
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VIVOS THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
VIVOS THERAPEUTICS INC 5-Tage-Chart

Aktuelle News zur VIVOS THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SoEarnings call: Vivos Therapeutics reports mixed Q1 results, aims for growth1
MiVivos Therapeutics, Inc. - 8-K, Current Report1
MiVivos Therapeutics GAAP EPS of -$1.63, revenue of $3.4M1
14.05.Vivos Therapeutics Inc reports results for the quarter ended in January - Earnings Summary-
14.05.Vivos Therapeutics, Inc. - 10-Q, Quarterly Report1
14.05.Vivos Therapeutics, Inc: Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call2
20.04.Vivos Therapeutics, Inc. - S-1/A, General form for registration of securities-
09.04.What's Going On With Vivos Therapeutics Stock?2
09.04.Why Is Vivos Therapeutics (VVOS) Stock Up 16% Today?1
09.04.Vivos Therapeutics, Inc: Vivos Therapeutics' Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement285LITTLETON, Colo., April 09, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and technology company specializing in the development...
► Artikel lesen
09.04.Vivos Therapeutics files to sell 1.73M shares of common stock for holders1
09.04.Vivos Therapeutics, Inc. - S-1, General form for registration of securities-
01.04.Vivos Therapeutics, Inc. (VVOS) Q4 2023 Earnings Call Transcript2
01.04.Earnings call: Vivos Therapeutics aims for cash flow positivity in 20241
28.03.Vivos Therapeutics Inc reports results for the quarter ended in December - Earnings Summary1
28.03.Vivos Therapeutics reports Q4 results1
28.03.Vivos Therapeutics, Inc. - 10-K, Annual Report1
28.03.Vivos Therapeutics, Inc: Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update252Positive Business Momentum and Sales Pipeline Growth Following FDA 510(k) Clearance of Vivos' Proprietary Oral Medical Devices to Treat Severe Obstructive Sleep Apnea Annual Operating Expenses Declined...
► Artikel lesen
28.03.Vivos Therapeutics, Inc: Vivos Therapeutics Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Conference Call1
15.02.Vivos Therapeutics, Inc. - 8-K, Current Report1
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1